IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
25 avr. 2024 16h05 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market...
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
13 mars 2024 16h30 HE
|
iRadimed Corporation
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
08 févr. 2024 08h05 HE
|
iRadimed Corporation
Reports record revenue of $17.5 million for the fourth quarter and $65.6 million for the full year of 2023. Reports GAAP diluted EPS of $0.36 and non-GAAP diluted EPS of $0.39 for the fourth quarter...
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
01 févr. 2024 16h05 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 fourth quarter financial results before the market...
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
09 janv. 2024 08h30 HE
|
iRadimed Corporation
Reports preliminary fourth quarter 2023 revenue of $17.5 million WINTER SPRINGS, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in developing...
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
02 janv. 2024 16h30 HE
|
iRadimed Corporation
IRADIMED CORPORATION Announces Participation in 42nd Annual J.P. Morgan Healthcare Conference
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
12 déc. 2023 10h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., Dec. 12, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) announced today that its Board of Directors approved a special cash dividend of $0.48 per...
IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes
30 nov. 2023 09h00 HE
|
iRadimed Corporation
WINTER SPRING, Fla., Nov. 30, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named on Forbes’ latest list of America’s Most Successful Small-Cap...
IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results
03 nov. 2023 08h00 HE
|
iRadimed Corporation
Reports record revenue of $16.5 million for the third quarter of 2023.GAAP diluted EPS of $0.40 and non-GAAP diluted EPS of $0.43.Third quarter operating income of $5.9 million, an increase of 43%...
IRADIMED CORPORATION to Hold 2023 Third Quarter Financial Results Conference Call on November 3rd
26 oct. 2023 16h05 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., Oct. 26, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 third quarter financial results before the market...